Methodology

Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran

Rasekh HR, Imani A, Karimi M, Golestani M

ClinicoEconomics and Outcomes Research 2011, 3:207-212

Published Date: 23 November 2011